First Page | Document Content | |
---|---|---|
Pharmaceutical sciences Food and Drug Administration Erythropoiesis-stimulating agents Growth factors Clinical research Adverse event Package insert Gadolinium Erythropoietin Pharmaceutical industry Medicine Pharmacology | FDA Patient Safety News: Show #62, April 2007Add to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 131,59 KBShare Document on Facebook |